Alert-based computerized decision support for high-risk hospitalized patients with atrial fibrillation not prescribed anticoagulation: a randomized, controlled trial (AF-ALERT).
暂无分享,去创建一个
A. Landman | S. Goldhaber | Benjamin Hohlfelder | G. Piazza | S. Emani | S. Hurwitz | B. Carroll | Claire E Galvin | Lindsay Harrigan | Sofia Baklla | Brett J. Carroll
[1] S. Goldhaber,et al. Fine-tuning the decision to initiate anticoagulation in atrial fibrillation by accounting for age and cardiovascular comorbidities. , 2019, European heart journal.
[2] Pamela J. McCabe,et al. Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation Is Achievable: First Results From Get With The Guidelines–Atrial Fibrillation (GWTG-AFIB) , 2019, Circulation.
[3] Michael A. Rodriguez,et al. Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry , 2019, Journal of the American Heart Association.
[4] D. Fitzmaurice,et al. Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation: Results From the GARFIELD-AF Registry , 2019, Circulation.
[5] G. Guyatt,et al. Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial , 2018, The Lancet.
[6] D. Fitzmaurice,et al. Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation , 2018, PloS one.
[7] S. Goldhaber,et al. Anticoagulation and Mortality Rates among Hospitalized Patients with Atrial Fibrillation , 2018, TH Open.
[8] Ameen Abu-Hanna,et al. The Effect of a Clinical Decision Support System on Improving Adherence to Guideline in the Treatment of Atrial Fibrillation: An Interrupted Time Series Study , 2018, Journal of Medical Systems.
[9] G. Fonarow,et al. International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD‐AF, ORBIT‐AF I, and ORBIT‐AF II registries , 2017, American heart journal.
[10] Mircea Cinteza,et al. A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial , 2017, The Lancet.
[11] D. Singer,et al. Absence of Oral Anticoagulation and Subsequent Outcomes Among Outpatients with Atrial Fibrillation. , 2017, The American journal of medicine.
[12] P. Kirchhof,et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, European heart journal.
[13] P. Magin,et al. Optimizing Stroke Prevention in Patients With Atrial Fibrillation: A Cluster-Randomized Controlled Trial of a Computerized Antithrombotic Risk Assessment Tool in Australian General Practice, 2012–2013 , 2016, Preventing chronic disease.
[14] D. Fitzmaurice,et al. Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF , 2016, European heart journal.
[15] Farzaneh A. Sorond,et al. North American Thrombosis Forum, AF Action Initiative Consensus Document. , 2016, The American journal of medicine.
[16] S. Goldhaber,et al. Randomized trial of physician alerts for thromboprophylaxis after discharge. , 2013, The American journal of medicine.
[17] Jeroen J. Bax,et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. , 2012, European heart journal.
[18] Isabelle Boutron,et al. Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors , 2012, BMJ : British Medical Journal.
[19] Douglas Weaver,et al. Third universal definition of myocardial infarction. , 2012, Circulation.
[20] D Bergqvist,et al. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients , 2010, Journal of thrombosis and haemostasis : JTH.
[21] Marilyn D Paterno,et al. Physician Alerts to Prevent Symptomatic Venous Thromboembolism in Hospitalized Patients , 2009, Circulation.
[22] S. Schulman,et al. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients , 2005, Journal of thrombosis and haemostasis : JTH.